Summary: Antibody-drug conjugates (ADCs) are a novel class of drugs that combine the potency of small molecule drugs with the targeting capabilities of highly-specific antibodies. While there is a wide array of different biochemical methods used for making ADCs, each method can have a varying effect on the stability of these types of therapeutics. In …
Pace Life Sciences – April 2020 Pace Life Sciences – April 2020 Delivering Science Better, Through Versatility: Virtual Audits & Lab Tours! We have made the necessary adjustments to protect our employees and their families and to remain fully operational through the COVID-19 Pandemic. We understand that it is our duty to do everything we …
Delivering Science Better, through Versatility: Virtual Audits & Lab Tours! Read More »
Pace Life Sciences – March 2020 Pace Supports Leading Biotech and Pharmaceutical Companies in Active Pursuit of COVID-19 Vaccines and Therapies Pace Analytical® labs and facilities are fully operational, providing essential Public Health Services as noted by the CDC. Due to our advanced capabilities in the development and testing of gene therapies and other complex …
Pace Life Sciences – March 2020 Pace Life Sciences Supporting Essential Healthcare Services Many Pace Life Sciences customers play a critical role in the healthcare industry to ensure patients receive the best treatments possible. As a provider of Essential Public Health Services, Pace is fully operational amid the COVID-19 pandemic, supporting our customers in their …
Pace Life Sciences Supporting Essential Healthcare Services Read More »
One of the more exciting areas of growth within our Life Sciences Division over the year has been the establishment of services designed to support the development of gene therapy. Gene therapy is designed to introduce genetic material into cells to compensate for abnormal genes or to make a beneficial protein. A gene that is …
Two decades of pharmaceutical development and customer service leads to exciting milestone Woburn, MA: Wolfe Laboratories, a subsidiary of Pace Analytical Life Sciences, has reached a special milestone as it celebrates 20 years as a premier contract research organization that provides integrated drug development solutions to the biopharmaceutical industry. Founded in 1999 by Senior Vice …
Pace’s Wolfe Laboratories Celebrates 20 Year Anniversary Read More »
At Pace Analytical we understand the importance of keeping up with changes in the marketplace. On March 1, 2019, a revision of USP <467>, Residual Solvents, will become effective. This revision clarifies verification and validation requirements for use of the monograph for Class 1, 2, and 3 residual solvent determination in compendial and non-compendial materials. …
Pace Life Sciences Ready for March 1st Changes to Residual Solvents Read More »
In conjunction with BIO International 2018, Pace Analytical Life Sciences is celebrating its first full year in Boston! Last year, Pace Analytical announced the acquisition of Wolfe Laboratories, Inc., a leading translational contract drug development company in the Boston area. The combined capabilities of the two organizations now offer the life science industry a one-stop-shop …
Wolfe Labs Part Of The Pace Life Sciences Family Read More »
Pace Analytical Life Sciences (PLS) has recently made significant investments to upgrade our capabilities and capacity for Total Organic Carbon (TOC) USP/EP testing. We have upgraded and standardized our equipment: we have purchased three new instruments and placed one within each of our FDA-registered, GMP-compliant testing laboratories: Oakdale, Minnesota Somerset, New Jersey San German, Puerto …
Pace Life Sciences is honored to be participating in the upcoming Convergence Forum, for Leaders in healthcare Innovation (http://convergenceforum.com/). The event will be hosted by Future Forward, during May 10 – 11, 2018, at the beautiful Wequassett Resort & Golf Club in Chatham, on Cape Cod, Massachusetts. Janet Wolfe, Ph.D., Founder and Senior Vice President …